Emmanuel J Favaloro/LinkedIn
Jan 9, 2026, 07:19
Emmanuel J Favaloro Shares the 1st Article in a VWD Series Marking the 100-Year Anniversary
Emmanuel J Favaloro, Lead Scientist at the Sydney Centres for Thrombosis and Haemostasis, Westmead Hospital, shared on LinkedIn:
”100 years of von Willebrand disease (VWD).
2026 marks the 100th year anniversary of the initial publication of a bleeding disorder “pseudo-hemophilia’ that was later to become known as von Willebrand disease.
Seminars in Thrombosis and Hemostasis will publish several papers on VWD in 2026.
This is the first one in queue – on type 2A VWD.
Enjoy!”
Read the full article here.
Article: Von Willebrand Disease Type 2A: An Update
Authors: Omid Seidizadeh , Luciano Baronciani , Pier Mannuccio Mannucci , Flora Peyvandi
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026
-
Jul 13, 2026, 17:39Pascal Boulanger: Send a Postcard to Your Lab Staff From ISTH 2026
-
Jul 13, 2026, 17:21Stefano Navarro: Presenting Our Recently Published Article at ISTH 2026